Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Convalescent Plasma vs Plasma-derived Immunoglobulin-enriched Solution in COVID-19 Patients
IRCT20200310046736N1Phase 3Not yet recruiting
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jun 2641
- Countries
- 1
01
Overview
Phase 3 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Planned start Jun 2641; status: not yet recruiting.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200310046736N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200310046736N1.